International Biotechnology (LON:IBT) Releases Earnings Results

International Biotechnology (LON:IBT) announced its earnings results on Tuesday. The company reported GBX (4.83) earnings per share for the quarter, Digital Look Earnings reports. The company had revenue of GBX 24 million during the quarter. International Biotechnology had a negative return on equity of 0.45% and a negative net margin of 6.26%.

International Biotechnology Trading Down 1.4%

Shares of IBT traded down GBX 14.16 on Tuesday, reaching GBX 975.84. 26,963 shares of the company’s stock were exchanged, compared to its average volume of 59,973. The stock has a market capitalization of £310.59 million, a P/E ratio of -296.61 and a beta of 0.49. The business has a 50 day moving average price of GBX 931.35 and a two-hundred day moving average price of GBX 928.16. International Biotechnology has a 12 month low of GBX 546 and a 12 month high of GBX 1,010.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.